Effect of Suboptimal Chemotherapy on Preoperative Chemoradiation in Rectal Cancer
![]() |
Lee, Ji-Hye
(Departments of Radiation Oncology, Seoul National University College of Medicine)
Kang, Hyun-Cheol (Departments of Radiation Oncology, Seoul National University College of Medicine) Chie, Eui-Kyu (Departments of Radiation Oncology, Seoul National University College of Medicine) Kang, Gyeong-Hoon (Departments of Pathology, Seoul National University College of Medicine) Park, Jae-Gahb (Departments of Surgery, Seoul National University College of Medicine) Oh, Do-Youn (Internal Medicine, Seoul National University College of Medicine) Im, Seock-Ah (Internal Medicine, Seoul National University College of Medicine) Kim, Tae-You (Internal Medicine, Seoul National University College of Medicine) Bang, Yung-Jue (Internal Medicine, Seoul National University College of Medicine) Ha, Sung-Whan (Departments of Radiation Oncology, Seoul National University College of Medicine) |
1 | NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450 DOI PUBMED ScienceOn |
2 | Kim J, Cho M, Song K, et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002;54:403-408 DOI PUBMED ScienceOn |
3 | Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-1472 DOI PUBMED ScienceOn |
4 | Krook J, Moertel C, Gunderson L, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715 DOI PUBMED ScienceOn |
5 | Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23 DOI ScienceOn |
6 | Aschele C, Friso M, Pucciarelli S, et al. A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005;16:1140-1146 DOI ScienceOn |
7 | Das P, Skibber J, Rodriguez-Bigas M, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007; 109:1750-1755 DOI ScienceOn |
8 | Mandard A, Dalibard F, Mandard J, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680-2686 DOI ScienceOn |
9 | Kapiteijn E, Marijnen C, Nagtegaal I, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646 DOI ScienceOn |
10 | Chang HJ, Park CK, Kim WH, et al. A standardized pathology report for colorectal cancer. Korean J Path 2006;40:193-203 |
11 | Glynne-Jones R, Sebag-Montefiore D, Maughan T, et al. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006;17:50-56 DOI ScienceOn |
12 | National Comprehensive Cancer Network. Clinical practice guidelines in oncology V.2. 2009: Rectal cancer. http://www.nccn.org/professionals/physician_gls/PDC/rectal.pdf |
13 | Saif M, Hashmi S, Zelterman D, et al. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis 2008;23: 139-145 DOI ScienceOn |
14 | O'Connell M, Martenson J, Wieand H, et al. Improving adjuvant therapy for rectal cancer by combining protractedinfusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-507 DOI ScienceOn |
15 | Mehta V, Cho C, Ford J, et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasoundstaged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003;55: 132-137 DOI ScienceOn |
16 | Choi SG, Bae HS. Results of preoperative concurrent chemoradiotherapy for locally advanced rectal cancer. J Korean Soc Ther Radiol Oncol 2007;25:34-42 |
17 | Twelves C, Wong A, Nowacki M, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005;352:2696-2704 DOI ScienceOn |
18 | Smalley S, Benedetti J, Williamson S, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006;24:3542-3547 DOI ScienceOn |
19 | Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99-107 DOI PUBMED ScienceOn |
20 | Pilipshen S, Heilweil M, Quan S, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53:1354-1362 DOI ScienceOn |
21 | Bazarbashi S, El-Bassiouni M, Abdelsalam M, et al. A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer. J Surg Oncol 2008; 98:167-174 DOI ScienceOn |
22 | de Bruin A, Nuyttens J, Ferenschild F, et al. Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med 2008;66:71-76 PUBMED |
23 | Di Costanzo F, Ravasio R, Sobrero A, et al. Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer: economic evaluation in an Italian NHS setting. Clin Drug Investig 2008;28:645-655 DOI ScienceOn |
24 | Douglass HJ, Moertel C, Mayer R, et al. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294-1295 DOI PUBMED ScienceOn |
25 | Korea Central Cancer Registry. 2002 Annual Report of the Korea Central Cancer Registry 2003 |
26 | Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740 DOI ScienceOn |
27 | Luna-Pérez P, Rodríguez-Ramírez S, Rodriguez-Coria D, et al. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma. World J Surg 2001;25:1006-1011 DOI ScienceOn |
28 | Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987-995 DOI ScienceOn |
29 | De Paoli A, Chiara S, Luppi G, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006;17:246-251 DOI ScienceOn |
30 | Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97:8-13 DOI ScienceOn |
31 | Scheithauer W, McKendrick J, Begbie S, et al. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol 2003;14:1735-1743 DOI ScienceOn |
32 | Dupuis O, Vie B, Lledo G, et al. Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study. Oncology 2007;73:169-176 DOI ScienceOn |
33 | Rullier E, Goffre B, Bonnel C, et al. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 2001;234:633-640 DOI ScienceOn |
![]() |